Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination

Journal of Viral Hepatitis

Volumn 17, Issue 12, 2010, Pages 872-878

  Boot, H J ^a   Hahne S ^a   Cremer, J ^a   Wong, A ^a   Boland, G ^b   Van Loon, A M ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

anti HBc; anti HBs; hepatitis B virus; maternal antibodies; perinatal transmission

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; MATERNAL ANTIBODY; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ANTIBODY TITER; ARTICLE; CHILD; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; PERINATAL INFECTION; PRIORITY JOURNAL; SEROLOGY; VACCINATION; VERTICAL TRANSMISSION;

CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION, PASSIVE; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINATION;

EID: 78649238599     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01247.x     Document Type: Article

References (24)

1. Hammitt LL, Hennessy TW, Fiore AE, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007; 25 (39-40): 6958 - 6964.
2. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC,. What level of hepatitis B antibody is protective? J Infect Dis 1999; 179 (2): 489 - 492.
3. WHO. Hepatitis B vaccines. Wkly Epidemiol Rec 2004; 79 (28): 255 - 263.
4. Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC,. The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond B Biol Sci 1993; 253 (1337): 197 - 201.
5. Di Marco V, Lo Iacono O, Camma C, et al. The long-term course of chronic hepatitis B. Hepatology 1999; 30 (1): 257 - 264.
6. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS,. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34 (6): 1329 - 1339.
7. Lee C, Gong Y, Brok J, Boxall EH, Gluud C,. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006; 332 (7537): 328 - 336.
8. Zanetti AR, Van Damme P, Shouval D,. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008; 26 (49): 6266 - 6273.
9. Averhoff F, Mahoney F, Coleman P, et al. Risk factors for lack of response to hepatitis B vaccines: a randomized trial comparing the immunogenicity of recombinant hepatitis B vaccines in an adult population. Am J Prev Med 1998; 15: 1 - 8.
10. Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH,. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 1998; 133 (3): 374 - 377.
11. Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67 (1): 20 - 26.
12. Andre FE, Zuckerman AJ,. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994; 44 (2): 144 - 151.
13. Del Canho R, Grosheide PM, Schalm SW, De Vries RR, Heijtink RA,. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994; 20 (4): 483 - 486.
14. Ip HM, Lelie PN, Wong VC, Kuhns MC, Reesink HW,. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989; 1 (8635): 406 - 410.
15. Yuan J, Lin J, Xu A, et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat 2006; 13 (9): 597 - 604.
16. Hyams KC,. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20 (4): 992 - 1000.
17. Blanpain C, Knoop C, Delforge ML, et al. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation 1998; 66 (7): 883 - 886.
18. Chamorro AJ, Casado JL, Bellido D, Moreno S,. Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker. Eur J Clin Microbiol Infect Dis 2005; 24 (7): 492 - 494.
19. Papaevangelou V, Hadjichristodoulou C, Cassimos DC, et al. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination. Infection 2008; 36 (2): 135 - 139.
20. Schalm SW, Mazel JA, De Gast GC, et al. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics 1989; 83 (6): 1041 - 1048.
21. Boot HJ, Cremer J, Koedijk FD, Van Ballegooijen WM, Op de Coul EL,. Improved tracing of hepatitis B virus transmission chains by phylogenetic analysis based on C region sequences. J Med Virol 2008; 80 (2): 233 - 241.
22. Stasinopoulos DM,. Generalized additive models for location scale and shape (GAMLSS) in R. J Stat Softw 2007; 23 (7): 1 - 46.
23. Walz A, Wirth S, Hucke J, Gerner P,. Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen. J Infect Dis 2009; 200 (8): 1227 - 1231.
24. Euler GL, Copeland JR, Rangel MC, Williams WW,. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women. Pediatr Infect Dis J 2003; 22 (2): 123 - 129.